IQVIA Holdings Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 13.87B | 14.41B | 14.98B | 15.40B | 16.31B | 5.9% | |
| Cost of Revenue | (9.23B) | (9.38B) | (9.74B) | (10.03B) | (12.02B) | 19.9% | |
Gross Profit | 4.64B | 5.03B | 5.24B | 5.38B | 4.29B | -20.3% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (1.96B) | (2.07B) | (2.05B) | (1.99B) | (2.00B) | 0.4% | |
| Depreciation & Amortization | (1.26B) | (1.13B) | (1.13B) | (1.11B) | (1.14B) | 2.7% | |
Operating Income (EBIT) | 1.39B | 1.80B | 1.98B | 2.20B | 2.29B | 3.9% | |
| Non-Operating Items | |||||||
| Interest Income | 6.00M | 13.00M | 36.00M | 47.00M | 45.00M | -4.3% | |
| Interest Expense | (375.00M) | (416.00M) | (672.00M) | (670.00M) | (729.00M) | 8.8% | |
| Other Income/Expenses (Net) | -259.00M | -448.00M | -518.00M | -533.00M | -674.00M | 26.5% | |
Income Before Tax | 1.13B | 1.35B | 1.46B | 1.67B | 1.61B | -3.4% | |
| Income Tax Expense | (163.00M) | (260.00M) | (101.00M) | (296.00M) | (252.00M) | -14.9% | |
Net Income | 966.00M | 1.09B | 1.36B | 1.37B | 1.36B | -0.9% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $5 | $6 | $7 | $8 | $8 | 4.5% | |
| Weighted Avg Shares Outstanding | 191.40M | 187.60M | 183.80M | 181.30M | 171.90M | -5.2% | |
| Weighted Avg Shares Outstanding (Diluted) | 195.00M | 190.60M | 186.30M | 183.40M | 173.50M | -5.4% | |
EBITDA | 2.77B | 2.91B | 3.26B | 3.45B | 3.46B | 0.3% |
Explore IQV
IQV in the Healthcare
Large Cap